Preventive Strategies Of Esophageal Stricture After Endoscopic Submucosal Dissection For Long-Segment And Circumferencial Esophageal Squamous Carcinoma: A Prospective Exploratory Study

Jingjing Lian,Yuan Chu,Meidong Xu,Tao Chen,Jia Cao
DOI: https://doi.org/10.1016/J.GIE.2020.03.1032
IF: 10.396
2020-01-01
Gastrointestinal Endoscopy
Abstract:Objectives: Endoscopic submucosal dissection (ESD) has become standard method for the treatment of superficial esophageal squamous cell carcinoma (SESCC). However, post-ESD esophageal stricture often occurs if patients suffer mucosal defects of more than three-quarters of the circumference of the esophagus, and even in almost 100% of cases after wholly circumferential ESD. As always, this unresolved problem has brought difficulties and challenges to endoscopic treatment for large-scale SESCC. We conducted a prospective study to exploring new ways to prevent esophageal stricture complicating long and full circumferential ESD. Patients expected to develop a long-segment and circular mucosal defect after esophageal ESD for SESCC were eligible for the study. Preventive strategies included 1) oral administration of corticosteroids: oral prednisolone began at a dose of 30 mg/day when the patient was permitted to start oral intake,tapered gradually (30, 25, 20, 15, 10, and 5 mg for 14 days each) and then discontinued. The total amount of prednisolone application time was 12 weeks; and 2) placement of a novel self-control stricture-preventing water balloon :the balloon was 2cm in diameter when completely filled with water and the length was made according to the mucosal defect.The device was inserted about 3-4 days after ESD. After discharge, patients used the device at home and made the balloon keeping filling except for during meals. The device would be removed about 8 weeks after ESD. The primary outcome was the incidence of esophageal stricture after ESD. The secondary outcomes included the number of esophageal balloon dilation (EBD) required for the management of the stricture, and adverse events. Between February 2018 to August 2019, 31 patients who met the eligibility criteria were included and 30 patients finished the 12-week both steroid treatment and balloon placement, with one patient transferred to surgery after ESD for deep tumor infiltration. The median length of lesions was 7.9 cm (range from 6cm to 13cm). All patients were followed up for at least 3 months. Only one male patient suffered from prolonged dysphagia and did not achieve complete remission despite 6 sessions of dilation and finally received esophagectomy. All the other 29 patients did not complain of dysphagia and no stenosis was found through gastroscopy in follow up. Balloon migration happened in four patients and was resolved by timely reinsertion . No perforation, bleeding, or infection related to the ESD occurred. Over the follow-up period, no significant adverse events were observed. Strategies of oral steroid administration plus placement of a novel self-control stricture-preventing water balloon seemed to be highly effective and safe to prevent against stricture in patients after esophageal ESD for long-segment and circumferential SESCC.4 days after ESD(the same case), a novel self-control stricture-preventing water balloon was inserted.View Large Image Figure ViewerDownload Hi-res image Download (PPT)
What problem does this paper attempt to address?